Chandan Healthcare Limited (NSE:CHANDAN)
India
· Delayed Price · Currency is INR 250.65
-10.35 (-3.97%)
At close: Mar 9, 2026
Chandan Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Operating Revenue | 2,635 | 2,301 | 1,766 | 1,369 | 1,196 | 871.63 |
| Other Revenue | 12.48 | 12.48 | 0.91 | - | - | 0 |
| Revenue | 2,647 | 2,314 | 1,767 | 1,369 | 1,196 | 871.63 |
| Revenue Growth (YoY) | - | 30.95% | 29.07% | 14.49% | 37.17% | - |
| Cost of Revenue | 1,323 | 1,105 | 826.12 | 666.72 | 634.11 | 401.04 |
| Gross Profit | 1,324 | 1,208 | 940.69 | 702.18 | 561.53 | 470.59 |
| Selling, General & Admin | 483.23 | 461.65 | 412.81 | 294.16 | 219.87 | 162.25 |
| Other Operating Expenses | 316.13 | 320.86 | 263.02 | 314.22 | 319.12 | 258.27 |
| Operating Expenses | 899.65 | 849.95 | 709.87 | 629.27 | 558.59 | 436.11 |
| Operating Income | 424.69 | 358.36 | 230.82 | 72.91 | 2.94 | 34.48 |
| Interest Expense | -48.53 | -40.53 | -24.81 | -18.02 | -15.99 | -18.95 |
| Interest & Investment Income | 7.3 | 7.3 | 10.64 | 0.8 | 1.46 | 0.12 |
| Other Non Operating Income (Expenses) | 14.93 | -4.48 | -2.05 | -5.58 | 0.99 | 0.97 |
| Pretax Income | 376.1 | 320.65 | 214.61 | 50.11 | -10.6 | 16.62 |
| Income Tax Expense | 99.74 | 85.49 | 51.05 | 14.25 | 0.32 | 7.76 |
| Earnings From Continuing Operations | 276.35 | 235.16 | 163.56 | 35.86 | -10.93 | 8.86 |
| Minority Interest in Earnings | -14.74 | -13.44 | -0.79 | -2.18 | -0.16 | - |
| Net Income | 261.62 | 221.71 | 162.77 | 33.68 | -11.09 | 8.86 |
| Net Income to Common | 261.62 | 221.71 | 162.77 | 33.68 | -11.09 | 8.86 |
| Net Income Growth | - | 36.21% | 383.29% | - | - | - |
| Shares Outstanding (Basic) | 24 | 21 | 20 | 20 | 20 | - |
| Shares Outstanding (Diluted) | 24 | 21 | 20 | 20 | 20 | - |
| Shares Change (YoY) | 16.71% | 2.86% | - | - | - | - |
| EPS (Basic) | 10.89 | 10.78 | 8.14 | 1.68 | -0.55 | - |
| EPS (Diluted) | 10.89 | 10.78 | 8.14 | 1.68 | -0.55 | - |
| EPS Growth | - | 32.42% | 384.44% | - | - | - |
| Free Cash Flow | - | -677.58 | -184.25 | -7.82 | -5.42 | - |
| Free Cash Flow Per Share | - | -32.94 | -9.21 | -0.39 | -0.27 | - |
| Dividend Per Share | - | - | 1.500 | 1.000 | 0.500 | - |
| Dividend Growth | - | - | 50.00% | 100.00% | - | - |
| Gross Margin | 50.03% | 52.23% | 53.24% | 51.30% | 46.97% | 53.99% |
| Operating Margin | 16.04% | 15.49% | 13.06% | 5.33% | 0.25% | 3.96% |
| Profit Margin | 9.88% | 9.58% | 9.21% | 2.46% | -0.93% | 1.02% |
| Free Cash Flow Margin | - | -29.29% | -10.43% | -0.57% | -0.45% | - |
| EBITDA | 525.58 | 425.81 | 264.86 | 93.8 | 22.54 | 50.07 |
| EBITDA Margin | 19.86% | 18.40% | 14.99% | 6.85% | 1.88% | 5.75% |
| D&A For EBITDA | 100.89 | 67.45 | 34.04 | 20.9 | 19.61 | 15.59 |
| EBIT | 424.69 | 358.36 | 230.82 | 72.91 | 2.94 | 34.48 |
| EBIT Margin | 16.04% | 15.49% | 13.06% | 5.33% | 0.25% | 3.96% |
| Effective Tax Rate | 26.52% | 26.66% | 23.79% | 28.43% | - | 46.68% |
| Revenue as Reported | 2,674 | 2,322 | 1,778 | 1,370 | 1,199 | 873.97 |
| Advertising Expenses | - | - | - | - | - | 0.14 |
Source: S&P Capital IQ. Standard template. Financial Sources.